Clinical Evaluation of Intravitreal Injection of Ganciclovir in Refractory Corneal Endotheliitis

REFERENCES

• Khodadoust AA, Attarzadeh A. Presumed autoimmune corneal endotheliopathy. Am J Ophthalmol. 1982;93:718–722. 7091259.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Ohashi Y. Corneal endotheliitis. Semin Ophthalmol. 2008;23:235–240. 18584561. doi:10.1080/08820530802111010.
   PubMedGoogle Scholar
• Ohashi Y, Yamamoto S, Nishida K, et al. Demonstration of herpes simplex virus DNA in idiopathic corneal endotheliopathy. Am J Ophthalmol. 1991;112:419–423. 1656756.
   PubMed Web of Science ®Google Scholar
• Maudgal PC, Missotten L, De Clercq E, Descamps J. Varicella-zoster virus in the human corneal endothelium: a case report. Bull Soc Belge Ophtalmol. 1980;190:71–86. 6269677.
   PubMedGoogle Scholar
• Koizumi N, Yamasaki K, Kawasaki S, et al. Cytomegalovirus in aqueous humor from an eye with corneal endotheliitis. Am J Ophthalmol. 2006;141:564–565. 16490509. doi:10.1016/j.ajo.2005.09.021.
   PubMed Web of Science ®Google Scholar
• Cavalcanti BM, Cruzat A, Sahin A, Pavan-Langston D, Samayoa E, Hamrah P. In vivo confocal microscopy detects bilateral changes of corneal immune cells and nerves in unilateral herpes zoster ophthalmicus. Ocul Surf. 2018;16:101–111. 28923503. doi:10.1016/j.jtos.2017.09.004.
   PubMed Web of Science ®Google Scholar
• Peng RM, Guo YX, Xiao GG, Lu Q, Sun BJ, Hong J. Clinical manifestations and characteristics of in vivo confocal microscopy in varicella zoster virus-related corneal endotheliitis. Ocul Immunol Inflamm. 2018:1–10. 30252558. doi:10.1080/09273948.2018.1521435.
   PubMed Web of Science ®Google Scholar
• Fukuda M, Deai T, Hibino T, Higaki S, Hayashi K, Shimomura Y. Quantitative analysis of herpes simplex virus genome in tears from patients with herpetic keratitis. Cornea. 2003;22(7 Suppl):S55–S60. 14703708.
   PubMed Web of Science ®Google Scholar
• Field AK, Davies ME, DeWitt C, et al. 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication. Proc Natl Acad Sci U S A. 1983;80:4139–4143. 6306664.
   PubMed Web of Science ®Google Scholar
• Chou TY, Hong BY. Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications. Ther Clin Risk Manag. 2014;10:665–681. 25187721. doi:10.2147/TCRM.S58242.
   PubMed Web of Science ®Google Scholar
• Colin J, Hoh HB, Easty DL, et al. Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis. Cornea. 1997;16:393–399. 9220235.
   PubMed Web of Science ®Google Scholar
• Koizumi N, Miyazaki D, Inoue T, et al. The effect of topical application of 0.15% ganciclovir gel on cytomegalovirus corneal endotheliitis. Br J Ophthalmol. 2017;101:114–119. 27142389. doi:10.1136/bjophthalmol-2015-308238.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang L, Wu N, Ma X, Xu J. Clinical efficacy of oral ganciclovir for prophylaxis and treatment of recurrent herpes simplex keratitis. Chin Med J (Engl). 2015;128:46–50. 25563312. doi:10.4103/0366-6999.147808.
   PubMed Web of Science ®Google Scholar
• Fan NW, Chung YC, Liu YC, et al. Long-term topical ganciclovir and corticosteroids preserve corneal endothelial function in cytomegalovirus corneal endotheliitis. Cornea. 2016;35:596–601. 26967107. doi:10.1097/ICO.0000-000000000791.
   PubMed Web of Science ®Google Scholar
• Carmichael A. Cytomegalovirus and the eye. Eye (Lond). 2012;26:237–240. 22173076. doi:10.1038/eye.2011.327.
   PubMed Web of Science ®Google Scholar
• Waduthantri S, Zhou L, Chee SP. Intra-cameral level of ganciclovir gel, 0.15% following topical application for cytomegalovirus anterior segment infection: A pilot study. PLoS One. 2018. doi:10.1371/journal.pone.0191850.29377953.
   PubMed Web of Science ®Google Scholar
• Crumpacker CS. Ganciclovir. N Engl J Med. 1996;335:721–729. 8786764. doi:10.1056/NEJM199609053351007.
   PubMed Web of Science ®Google Scholar
• Marshall BC, Koch WC. Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events. Paediatr Drugs. 2009;11:309–321. 19725597. doi:10.2165/11316080-000000000-00000.
   PubMedGoogle Scholar
• Choi WS, Cho JH, Kim HK, Kim HS, Shin YJ. A case of CMV endotheliitis treated with intravitreal ganciclovir injection. Korean J Ophthalmol. 2013;27:130–132. 23543604. doi:10.3341/kjo.2013.27.2.130.
   PubMedGoogle Scholar
• Ghate D, Edelhauser HF. Ocular drug delivery. Expert Opin Drug Deliv. 2006;3:275–287. 16506953. doi:10.1517/17425247.3.2.275.
   PubMed Web of Science ®Google Scholar
• Janoria KG, Boddu SH, Wang Z, et al. Vitreal pharmacokinetics of biotinylated ganciclovir: role of sodium-dependent multivitamin transporter expressed on retina. J Ocul Pharmacol Ther. 2009;25:39–49. 19232011. doi:10.1089/jop.2008.0040.
   PubMed Web of Science ®Google Scholar
• Hwang YS, Lin KK, Lee JS, et al. Intravitreal loading injection of ganciclovir with or without adjunctive oral valganciclovir for cytomegalovirus anterior uveitis. Graefes Arch Clin Exp Ophthalmol. 2010;248:263–269. 19784845. doi:10.1007/s00417-009-1195-2.
   PubMed Web of Science ®Google Scholar
• Hwang YS, Shen CR, Chang SH, et al. The validity of clinical feature profiles for cytomegaloviral anterior segment infection. Graefes Arch Clin Exp Ophthalmol. 2011;249:103–110. 20857136. doi:10.1007/s00417-010-1510-y.
   PubMed Web of Science ®Google Scholar
• Teoh SC, Ou X, Lim TH. Intravitreal ganciclovir maintenance injection for cytomegalovirus retinitis: efficacy of a low-volume, intermediate-dose regimen. Ophthalmology. 2012;119:588–595. 22137552. doi:10.1016/j.ophtha.2011.09.004.
   PubMed Web of Science ®Google Scholar
• Arevalo JF, Garcia RA, Mendoza AJ. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela. Eur J Ophthalmol. 2005;15:610–618. 16167292.
   PubMed Web of Science ®Google Scholar
• Wang B, Tian B, Tao Y, Hou J, Zhao X-T, Li -X-X. Continued decline of aqueous interleukin-8 after multiple intravitreal injections of ganciclovir for cytomegalovirus retinitis. J Ocul Pharmacol Ther. 2014;30:587–592. 24874926. doi:10.1089/jop.2013.0241.
   PubMed Web of Science ®Google Scholar
• Chee SP, Bacsal K, Jap A, Se-Thoe S-Y, Cheng CL, Tan BH. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol. 2008;145:834–840. 18255045. doi:10.1016/j.ajo.2007.12.015.
   PubMed Web of Science ®Google Scholar
• Holladay JT. Visual acuity measurements. J Cataract Refract Surg. 2004;30:287–290. 15030802. doi:10.1016/j.jcrs.2004.01.014.
   PubMed Web of Science ®Google Scholar
• Sridhar J, Yonekawa Y, Kuriyan AE, et al. Microbiologic spectrum and visual outcomes of acute-onset endophthalmitis undergoing therapeutic pars plana vitrectomy. Retina. 2017;37:1246–1251. 27779558. doi:10.1097/IAE.0000-000000001358.
   PubMed Web of Science ®Google Scholar
• Kongyai N, Sirirungsi W, Pathanapitoon K, et al. Viral causes of unexplained anterior uveitis in Thailand. Eye (Lond). 2012;26:529–534. 22241022. doi:10.1038/eye.2011.363.
   PubMed Web of Science ®Google Scholar
• Santos FF, Commodaro AG, Souza AV, et al. Real-time PCR in infectious uveitis as an alternative diagnosis. Arq Bras Oftalmol. 2011;74:258–261. 22068852.
   PubMed Web of Science ®Google Scholar
• Ang M, Sng CC, Chee SP, et al. Outcomes of corneal transplantation for irreversible corneal decompensation secondary to corneal endotheliitis in Asian eyes. Am J Ophthalmol. 2013;156:260–266. e2.23622566. doi:10.1016/j.ajo.2013.03.020.
   PubMed Web of Science ®Google Scholar
• Kam KW, Leung KS, Kwok RP, et al. Clinical features, diagnosis and treatment outcomes of cytomegalovirus endotheliitis in Hong Kong. Acta Ophthalmol. 2016. doi:10.1111/aos.13109. [Epub ahead of print].27306329.
   PubMed Web of Science ®Google Scholar
• Inoue Y. Review of clinical and basic approaches to corneal endotheliitis. Cornea. 2014;33:(Suppl 11):S3–S8. 25170583. doi:10.1097/ICO.0000000000000228.
   PubMedGoogle Scholar
• Schulman J, Peyman GA, Fiscella R, Greenberg D, Horton MB, de Miranda P. Intraocular acyclovir levels after subconjunctival and topical administration. Br J Ophthalmol. 1986;70:138–140. 3947611.
   PubMed Web of Science ®Google Scholar
• Chee SP, Jap A. Cytomegalovirus anterior uveitis: outcome of treatment. Br J Ophthalmol. 2010;94:1648–1652. 20576767. doi:10.1136/bjo.2009.167767.
   PubMed Web of Science ®Google Scholar
• Winston DJ, Busuttil RW. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients. Transplantation. 2003;75:229–233. 12548129. doi:10.1097/01.TP.0000040601.60276.96.
   PubMed Web of Science ®Google Scholar
• Boivin G, Gilbert C, Gaudreau A, Greenfield I, Sudlow R, Roberts NA. Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as induction and maintenance therapy for CMV retinitis. J Infect Dis. 2001;184:1598–1602. 11740736. doi:10.1086/324672.
   PubMed Web of Science ®Google Scholar